Intra-articular Pulsed Radiofrequency With Steroids Injection Versus Intra-articular Steroids Injection in Chronic Sacroiliac Joint Arthritis

Assiut University

Status and phase: Completed; Phase 3; Phase 2

Conditions: Pain Management

Treatments: Drug: intraarticular radiofrequency + intraarticular methylprednisolone; Drug: intraarticular methylprednisolone

Study type: Interventional

Funder types: Other

Identifiers

NCT03564106

17200203

Details and patient eligibility

About

The sacroiliac joint is Located between the pelvis and base of the spine, the sacroiliac joints are strong, stable joints that allow for little movement. While these joints do not bend like a knuckle or knee, they are susceptible to degenerative arthritis. Sacroiliac joint pain is one of the most common causes of chronic low back pain, accounting for 10% to 27% of patients with chronic lower back pain. It is known to be caused by abnormal motion in this joint, namely, too much motion or too little motion. Patients with pain experience various degrees of pain in the low back, groin, buttock, or posterior thigh.

Full description

The pain starts when the Sacroiliac joint gets inflamed. There are several reasons it could happen. It could be hurt when playing sports or if fall down.

Sometimes start hurting when the ligaments that hold the SI joint together are damaged, which may make the joint move abnormally. The pain associated with sacroiliitis most commonly occurs in the buttocks and lower back. It can also affect the legs, groin and even the feet.

Enrollment: 40 patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• All patients must have chronic pain more than 6 months and have failed medical treatment.

Exclusion criteria

• Infection at the site of injection
• Opioids addiction
• Coagulopathy or another bleeding diathesis
• Those who refuse to participate in the study
• Ankylosing Spondylitis patients

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

40 participants in 2 patient groups

group A

Experimental group

Description:

receive intraarticular radiofrequency + methylprednisolone (30 mg)

Treatment:

Drug: intraarticular radiofrequency + intraarticular methylprednisolone

group C

Experimental group

Description:

receive intraarticular methylprednisolone (30 mg)

Treatment:

Drug: intraarticular methylprednisolone